Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROCLAME topical clobetasol for inflammatory hand osteoarthritis
2025-520678-20-00Phase 3Authorised
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in hand osteoarthritis comparing Clobetasol propionate with Placebo (2 arms). Primary endpoint: Primary: change in hand pain VAS from baseline to week 4. Planned start Aug 2026; status: authorised.
02
Drugs
clobetasol
03
Conditions
hand osteoarthritis
Beyond the preview
Go deeper on 2025-520678-20-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-520678-20-00.